Trifluoroacetic anhydride

We are Trifluoroacetic anhydride CAS:407-25-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: Trifluoroacetic anhydride
CAS.NO:407-25-0
Synonyms:
trifluoro acetic anhydride
hexafluoroacetic anhydride
TRIFLUOROACETO ANHYDRIDE
bis-trifluoroacetic anhydride
trifluoroacetylanhydride
TRIFLUORACETIC ANHYDRIDE
2,2,2-trifluoroacetic anhydride
Trifluoroacetic Anhydride (TFAA)
Acetic acid, trifluoro-, anhydride
TIFLUOROACETIC ANHYDRIDE
Trifluoroacetic anhy
RIFLUOROACETIC ANHYDRIDE
trifluoroacetic
Perfluoracetic anhydride
trifluoroacetic acid anhydride
perfluoroaceticanhydride

Molecular Formula:C4F6O3
Molecular Weight:210.03100

Physical and Chemical Properties:
Density: 1.511 g / mL at 20 ° C (lit.)
Boiling point: 39.5-40 ° C (lit.)
Melting point: -63.5 ° C
Flash point: -26 ° C
Refractive index: n20 / D 1.3 (lit.)

Specification:
Appearance:Colorless transparent liquid
Purity:≥99%
Sulphate:≤0.05% 
Fluoride:≤0.005% 
Chloride:≤0.005%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:-20°C Freezer.Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Olanzapine Pamoate Hydrate CAS:221373-18-8
Intermediates of Olanzapine  CAS:132539-06-1
Intermediates of Chlorfenapyr CAS:122453-73-0

Related News: The insulin-only and bihormonal configurations may be helpful in diabetes.3-bromo-4-clorobenzotrifluoruro CAS:454-78-4 The insulin-only and bihormonal configurations may be helpful in diabetes.2,3-Difluorobenzaldehyde CAS:2646-91-5 Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for cancer and immune disorders.Ethyl 2-Bromoisovalerate As the global generic drug market booms and the international API industry accelerates its transfer to developing countries, China and India rely on cost advantages to rapidly grow into major API producers and exporters.As the global generic drug market booms and the international API industry accelerates its transfer to developing countries, China and India rely on cost advantages to rapidly grow into major API producers and exporters.